BioVie is Biotechnology in United States that focus on neuro-degenerative disorders business. Founded in 2013. They cover business area such as BioVie Inc, innovative drug therapy, chronic debilitate condition, liver disease, neurological and neuro-degenerative disorder, certain cancer, ascite, chronic liver cirrhosis, thousand, patient, life-threaten complication, hepatitis, non-alcoholic steatohepatitis, alcoholism, NeurMedix Inc, inflammatory activation, ERK, NFB.
2013
( 11 years old in 2024 )
Neuro-degenerative Disorders
-
2120 Colorado Avenue
Suite 230
Santa Monica, CA 90404
United States
Private
BioVie Incinnovative drug therapychronic debilitate conditionliver diseaseneurological and neuro-degenerative disordercertain cancerascitechronic liver cirrhosisthousandpatientlife-threaten complicationhepatitis, non-alcoholic steatohepatitisalcoholismNeurMedix Incinflammatory activationERKNFB
* We use standard office opening hours in near BioVie's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
BioVie is Biotechnology business from United States that founded in 2013 (11 years old in 2024), BioVie business is focusing on Neuro-degenerative Disorders.
BioVie headquarter office and corporate office address is located in 2120 Colorado Avenue Suite 230 Santa Monica, CA 90404 United States.
BioVie was founded in United States.
In 2024, BioVie is currently focus on neuro-degenerative disorders sector.
Above is snippet of Google Trends for "neuro-degenerative disorders" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with BioVie, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
